What Is Generalized Pustular Psoriasis (GPP)? Symptoms, Causes, Diagnosis, Treatment, and Prevention

Unlike localized pustular psoriasis, which occurs on one area of the body, a GPP flare involves a widespread rash with pustules, or small bumps containing pus (a white or yellow fluid filled with dead white blood cells).
Types of GPP
“In psoriasis, there are microscopic little collections of pus cells,” says Steven Feldman, MD, PhD, a dermatologist who specializes in psoriasis at Atrium Health Wake Forest Baptist in Winston-Salem, North Carolina. “But in generalized pustular psoriasis, which is a very abrupt and severe flare, people get the psoriasis all over their body, and those little microscopic pus cells get so large that they are visible with the naked eye.”
In severe cases, GPP can become life-threatening if left untreated.
- Acute GPP
- Annular pustular psoriasis
- Localized or chronic acral GPP
- Pustular psoriasis of pregnancy
- Infantile and juvenile pustular psoriasis
- Mixed GPP
Acute GPP
Annular Pustular Psoriasis
Localized or Chronic Acral GPP
Pustular Psoriasis of Pregnancy
Infantile and Juvenile Pustular Psoriasis
Mixed GPP
Signs and Symptoms of Generalized Pustular Psoriasis
- Fever
- Chills and shivers
- Intense itching
- Rapid pulse
- Fatigue
- Headache
- Nausea
- Muscle weakness
- Joint pain
Causes and Risk Factors of Generalized Pustular Psoriasis
“People have psoriasis in part due to their genetics, and so they’ll be predisposed to having psoriasis, but then they’ll get an infection or be exposed to some drug that activates their immune system and causes the psoriasis to severely flare up,” Dr. Feldman says.
- Illness or infection
- Use of certain medications These may include withdrawal from corticosteroid treatment, as well as antibiotics and antifungals, Feldman says.
- Pregnancy
- Psychological stress
- Hypocalcemia This is a condition that results from an abnormally low level of calcium in your blood
How Is Generalized Pustular Psoriasis Diagnosed?
To diagnose GPP, a doctor will perform a physical exam, ask about your medical history, review symptoms, examine a sample of skin tissue (biopsy), and possibly test pustules to rule out other potential causes. Psoriasis or a history of psoriasis could indicate GPP for some but not all people.
Doctors unfamiliar with GPP may misdiagnose symptoms as an infection or simple psoriasis, especially in patients experiencing a flare for the first time.
Prognosis of Generalized Pustular Psoriasis
Treatment and Medication Options for Generalized Pustular Psoriasis
When a GPP flare occurs, it’s important to get it under control as soon as possible to avoid complications, Feldman says.
Spesolimab (Spevigo) for GPP
Delivered by injection, the drug blocks the activation of the interleukin-36 receptor (IL-36R), a key part of a signaling pathway within the immune system involved in GPP.
Psoriasis Medications
- Oral retinoid Oral retinoids are derived from vitamin A. They are usually reserved for severe psoriasis, and research about their efficacy is limited.
- Biologics Biologics target the part of the immune system that is overactive because of psoriasis, decreasing inflammation and bumps quickly. Medications in this class include:
- infliximab (Remicade)
- adalimumab (Humira)
- etanercept (Enbrel)
- apremilast (Otezla) This drug works by controlling inflammation in the immune cells.
- methotrexate (Jylamvo, Otrexup, Rasuvo) This strong medication suppresses the overactive immune system.
- cyclosporine (Sandimmune, Neoral) This fast-acting medication also works by suppressing the immune system, Feldman says.
In addition to these systemic treatments that focus on the immune system, physicians also need to address specific skin issues.
“Often, the skin of someone with GPP is treated in the same way that a person with severe burns would be treated — with special kinds of bandages, special emollients, and antibiotics,” Feldman says.
Prevention of Generalized Pustular Psoriasis
GPP triggers can vary from person to person; trying to avoid or limit exposure to known triggers can help reduce the risk of a flare.
“If [the trigger is] a medication, then you want to avoid that medication,” Feldman says.
If infections are a trigger, that’s more difficult. You can’t always avoid getting them. But if you do, your doctor should monitor you closely, Feldman says.
You may want to talk to your doctor or healthcare provider about vaccinations as a means to help prevent infections, such as the flu, COVID-19, and others.
Lifestyle Changes for GPP
- Losing weight
- Avoiding alcohol and smoking, Feldman says
- Keeping your skin moist
- Exercising
- Managing your stress
Complications of Generalized Pustular Psoriasis
- Sepsis, a condition in which the body’s response to infection damages its own tissue
- Acute respiratory distress syndrome, in which fluid collects in the lungs’ air sacs, depriving organs of oxygen
- Cardiac failure
- Acute renal failure
- Heart failure
Feldman says, however, that advances in medications may be making these complications less common.
Research and Statistics: Who Has Generalized Pustular Psoriasis?
GPP can affect people of any skin color, Feldman says.
- United Kingdom
- Germany
- Tunisia
- Malaysia
- China
- Japan
Related Conditions to Generalized Pustular Psoriasis
Plaques are raised, inflamed, and scaly patches of skin that can be painful and itchy. On white skin, they usually look red with a silvery white buildup of scales. On darker skin tones, the plaques may appear thicker and more of a purple, gray, or dark brown color.
Plaques can appear anywhere on the body but they occur most often on the scalp, knees, elbows, and torso.
Support for People With Generalized Pustular Psoriasis
Mental health can play an important role in managing flares, treatment, and stress.
You may find support from friends and family, but you may also benefit from finding other people near you or online who also live with psoriasis.
National Psoriasis Foundation
The National Psoriasis Foundation offers help with finding other people living with psoriasis, as well as ways to get involved in its community and to seek help for children and teens.
Inspire Community Forum
Inspire’s network of online support groups includes a forum designed for people living with psoriasis.
Psoriasis Association
This organization, based in the United Kingdom, offers online forums, a private Facebook group, and ways to share your personal story.
Your healthcare provider may have additional resources for you to explore, as well.
The Takeaway
- Generalized pustular psoriasis (GPP) is rare but can be lethal, with a 5 to 10 percent fatality rate.
- The condition may be more common in women than men, and it can affect people of any age.
- Treatments can help prevent complications and flares.
- During a flare, you should seek medical attention if you develop other symptoms, such as fever.
Resources We Trust
- Cleveland Clinic: Pustular Psoriasis
- Mayo Clinic: Types of Psoriasis
- StatPearls: Generalized Pustular Psoriasis
- National Psoriasis Foundation: Generalized Pustular Psoriasis
- American Journal of Clinical Dermatology: Treatment Options and Goals for Patients With Generalized Pustular Psoriasis
- Pustular Psoriasis. Cleveland Clinic. March 2023.
- Prajapati VH et al. Considerations for defining and diagnosing generalized pustular psoriasis. Journal of the European Academy of Dermatology and Venereology. September 2024.
- Zheng M et al. The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis. American Journal of Clinical Dermatology. January 2022.
- Seishima M et al. Generalized Pustular Psoriasis in Pregnancy: Current and Future Treatments. American Journal of Clinical Dermatology. September 2022.
- Arasiewicz H et al. Successful treatment of a child’s generalized pustular psoriasis with adalimumab in combination with low-dose acitretin. Advances in Dermatology and Allergology. July 2023.
- Understanding Pustular Psoriasis. National Psoriasis Foundation. September 2021.
- Mirza HA et al. Generalized Pustular Psoriasis. StatPearls. September 2022.
- Wolf P et al. Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert Network. Journal of the European Academy of Dermatology and Venereology. January 27, 2024.
- Krueger J et al. Treatment Options and Goals for Patients with Generalized Pustular Psoriasis. American Journal of Clinical Dermatology. January 2022.
- Rivera-Díaz R et al. Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment. Dermatology and Therapy. December 19, 2022.
- Choon SE et al. Clinical Course and Characteristics of Generalized Pustular Psoriasis. American Journal of Clinical Dermatology. January 2022.
- Gottlieb AB et al. All-Cause Mortality is Higher in Generalized Pustular Psoriasis (GPP) than Plaque Psoriasis and the General Population: A US-Based Claims Analysis. Journal of Psoriasis and Psoriatic Arthritis. May 30, 2025.
- Blair HA. Spesolimab: First Approval. Drugs. January 2023.
- Ludmann P. Pustular psoriasis: Treatment. American Academy of Dermatology Association. August 2024.
- Psoriasis Treatment: Apermilast. American Academy of Dermatology Association.
- Psoriasis Treatment: Methotrexate. American Academy of Dermatology Association.
- Long V et al. Psoriasis Flares and Rebound Phenomenon Following Exposure and Withdrawal of Systemic Steroids: A Systematic Review and Meta-Analysis. Journal of the American Academy of Dermatology. September 2022.
- Healthy diet and other lifestyle changes that can improve psoriasis. American Academy of Dermatology Association.
- Rivera-Díaz R et al. Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment. Dermatology and Therapy. January 2023.
- Armstrong AW et al. Generalized pustular psoriasis: A consensus statement from the National Psoriasis Foundation. Journal of the Academy of Dermatology. April 2024.
- Generalized Pustular Psoriasis. National Psoriasis Foundation. April 17, 2025.
- Plaque Psoriasis. National Psoriasis Foundation. March 2025.

Susan Bard, MD
Medical Reviewer
Susan Bard, MD, is a clinical instructor in the department of dermatology at Weill Cornell Medicine and an adjunct clinical instructor in the department of dermatology at Mount Sinai in New York City. Her professional interests include Mohs micrographic surgery, cosmetic and laser procedures, and immunodermatology.
She is a procedural dermatologist with the American Board of Dermatology and a fellow of the American College of Mohs Surgery.
Dr. Bard has written numerous book chapters and articles for many prominent peer-reviewed journals, and authored the textbook The Laser Treatment of Vascular Lesions.

Becky Upham
Author
Becky Upham has worked throughout the health and wellness world for over 25 years. She's been a race director, a team recruiter for the Leukemia and Lymphoma Society, a salesperson for a major pharmaceutical company, a blogger for Moogfest, a communications manager for Mission Health, a fitness instructor, and a health coach.
Upham majored in English at the University of North Carolina and has a master's in English writing from Hollins University.
Upham enjoys teaching cycling classes, running, reading fiction, and making playlists.